𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1169 GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C

✍ Scribed by Kurosaki, M.; Tanaka, Y.; Nishida, N.; Sugiyama, M.; Matsuura, K.; Asahina, Y.; Sugauchi, F.; Sakamoto, N.; Nakagawa, M.; Watanabe, M.; Sakai, A.; Honda, M.; Kaneko, S.; Ito, K.; Masaki, N.; Tokunaga, K.; Izumi, N.; Mizokami, M.


Book ID
123054071
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
70 KB
Volume
52
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interleukin 28B polymorphism predicts pe
✍ Stella De Nicola; Alessio Aghemo; Maria Grazia Rumi; Enrico Galmozzi; Luca Valen πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 1 views

Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest baseline predictors of a sustained virologic response (SVR) to peg-interferon (PegIFN) and ribavirin (Rbv) in patients with hepatitis C virus (HCV) genotype 1 infection. Whether this holds true for HCV-4